Cyclosporine in the treatment of dermatologic disease: An update

被引:46
作者
Lim, KK
Su, WPD
Schroeter, AL
Sabers, CJ
Abraham, RT
Pittelkow, MR
机构
[1] MAYO CLIN & MAYO FDN, DEPT DERMATOL, ROCHESTER, MN 55905 USA
[2] MAYO CLIN & MAYO FDN, DEPT IMMUNOL, ROCHESTER, MN 55905 USA
关键词
D O I
10.4065/71.12.1182
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Treatment with cyclosporine is beneficial for many dermatologic diseases such as psoriasis, lichen planus, Behcet disease, atopic dermatitis, pyoderma gangrenosum, and epidermolysis bullosa acquisita, The selective action of cyclosporine on helper T cells and its rapid therapeutic action and weak myelotoxicity are the key advantages in the treatment of many dermatologic diseases, Nevertheless, drug toxicity, especially nephrotoxicity high rates of relapse after treatment cessation, and high cost have limited its use to those diseases refractory to other therapies, Herein we discuss the use of cyclosporine for dermatologic diseases relative to efficacy, dosage, safety profile, and monitoring. In addition, we review the formulations and metabolism of cyclosporine; discuss its mechanism of action, clinical indications in dermatology, and side effects; and provide usage guidelines for this drug, Cyclosporine can be safely administered when potential toxicities, dosing, and monitoring guidelines are known.
引用
收藏
页码:1182 / 1191
页数:10
相关论文
共 92 条
[1]  
AMERIO P, 1994, ACTA DERM-VENEREOL, V74, P101
[2]   RESPONSE OF NAIL PSORIASIS TO CYCLOSPORINE [J].
ARNOLD, WP ;
GERRITSEN, MJP ;
VANDEKERKHOF, PCM .
BRITISH JOURNAL OF DERMATOLOGY, 1993, 129 (06) :750-751
[3]   TOPICAL CYCLOSPORINE FOR CICATRICIAL PEMPHIGOID [J].
AZANA, JM ;
DEMISA, RF ;
BOIXEDA, JP ;
LEDO, A .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1993, 28 (01) :134-134
[4]   TREATMENT OF 9 CASES OF PEMPHIGUS VULGARIS WITH CYCLOSPORINE [J].
BARTHELEMY, H ;
FRAPPAZ, A ;
CAMBAZARD, F ;
MAUDUIT, G ;
ROUCHOUSE, B ;
KANITAKIS, J ;
SOUTEYRAND, P ;
CLAUDY, AL ;
THIVOLET, J .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1988, 18 (06) :1262-1266
[5]   BENIGN FAMILIAL CHRONIC PEMPHIGUS (HAILEY-HAILEY DISEASE) RESPONDS TO CYCLOSPORINE [J].
BERTHJONES, J ;
SMITH, SG ;
GRAHAMBROWN, RAC .
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 1995, 20 (01) :70-72
[6]   BULLOUS PEMPHIGOID AND SEVERE ERYTHRODERMIC PSORIASIS - COMBINED LOW-DOSE TREATMENT WITH CYCLOSPORINE AND SYSTEMIC STEROIDS [J].
BIANCHI, L ;
GATTI, S ;
NINI, G .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1992, 27 (02) :278-278
[7]   PROBING IMMUNOSUPPRESSANT ACTION WITH A NONNATURAL IMMUNOPHILIN LIGAND [J].
BIERER, BE ;
SOMERS, PK ;
WANDLESS, TJ ;
BURAKOFF, SJ ;
SCHREIBER, SL .
SCIENCE, 1990, 250 (4980) :556-559
[8]   2 DISTINCT SIGNAL TRANSMISSION PATHWAYS IN LYMPHOCYTES-T ARE INHIBITED BY COMPLEXES FORMED BETWEEN AN IMMUNOPHILIN AND EITHER FK506 OR RAPAMYCIN [J].
BIERER, BE ;
MATTILA, PS ;
STANDAERT, RF ;
HERZENBERG, LA ;
BURAKOFF, SJ ;
CRABTREE, G ;
SCHREIBER, SL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (23) :9231-9235
[9]   A new microemulsion formulation of cyclosporin (Neoral) is effective in the treatment of cyclosporin-resistant dermatoses [J].
Bourke, JF ;
BerthJones, J ;
Holder, J ;
GrahamBrown, RAC .
BRITISH JOURNAL OF DERMATOLOGY, 1996, 134 (04) :777-779
[10]   IDENTIFICATION OF THE IMMUNOPHILINS CAPABLE OF MEDIATING INHIBITION OF SIGNAL-TRANSDUCTION BY CYCLOSPORINE-A AND FK506 - ROLES OF CALCINEURIN BINDING AND CELLULAR LOCATION [J].
BRAM, RJ ;
HUNG, DT ;
MARTIN, PK ;
SCHREIBER, SL ;
CRABTREE, GR .
MOLECULAR AND CELLULAR BIOLOGY, 1993, 13 (08) :4760-4769